Market Cap 20.71B
Revenue (ttm) 2.88B
Net Income (ttm) 1.20B
EPS (ttm) N/A
PE Ratio 18.23
Forward PE 17.86
Profit Margin 41.53%
Debt to Equity Ratio 0.00
Volume 303,000
Avg Vol 574,858
Day's Range N/A - N/A
Shares Out 43.06M
Stochastic %K 87%
Beta 0.86
Analysts Strong Sell
Price Target $511.00

Company Profile

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to d...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 301 608 9292
Address:
1000 Spring Street, Silver Spring, United States
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:04 AM
Actionable Trade Alert for $UTHR: Market Context: $UTHR closed at $484.1, showing bullish momentum but is currently overbought with an RSI of 70.14. The stock is above both the 30-day MA (459.88) and the 50-day MA (450.52), indicating a strong upward trend. However, caution is warranted due to the high RSI. Directional Bias: The bullish trend is supported by the proximity to the 60-day high of $492.62. The stock has room to move higher, but the overbought condition suggests a potential pullback. Trade Plan: - Suggested Entry: $484.1 - Stop Loss: $470.0 (3% below entry) - Take Profit Targets: 1. $490.0 (1.24% gain) 2. $495.0 (2.26% gain) 3. $510.0 (5.36% gain) Target 3 offers a potential ROI of 17% from the entry price. Monitor RSI for signs of reversal and adjust accordingly. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
VJLer
VJLer Dec. 5 at 1:55 PM
$DDD some of the narratives are incredibly exciting. I could imagine this being acqired or doing licensing deals with companies. But lately nothing is happening. Couls imagine deals with $HPQ or $UTHR or an entity that is in dental supply or a medical device company. And at current market cap the purchase price would probably be arelative pittance.
0 · Reply
clan
clan Dec. 5 at 10:13 AM
$MNKD Ya never know. $CIPLA.NSE and their $1.2TRILLION market cap could snatch up $UTHR AND Mannkind for a cool measly $50 Billion [split: Unither $40B + MannKind $10B ]. 🇮🇳🇺🇸
0 · Reply
clan
clan Dec. 5 at 9:28 AM
$MNKD is up 29% over the recent 6 months for a multitude and combination of reasons. To certainly go higher as time moves forward. Onward and upward. ↗️ In part due to $UTHR $SCPH and $BX #afrezza #inhalemyinsulin
0 · Reply
Affizle
Affizle Dec. 4 at 7:48 PM
$MNKD Food for thought $LQDA +185% YTD $UTHR +37% YTD $SPY + 16% YTD $NDAQ +16% YTD $MNKD a BIG NEGATIVE 13% YTD! oopsies for Mannkindsies! LOLZ!
0 · Reply
bemore
bemore Dec. 4 at 4:19 PM
$INSM from IV, Rothschild & Co Redburn🏁 $INSM Buy/$263 $LQDA $UTHR Rothschild & Co Redburn said—Insmed is well positioned in large therapy areas with limited competition. With the recent approvals of Brinsupri, a first-in-class therapy for bronchiectasis, we anticipate strong uptake given the lack of competitors. Along with potential indication expansion opportunities, we believe Brinsupri has peak sales of c$12BN, above the consensus median of c$10BN. TPIP is the next important growth driver with multi-billion-dollar blockbuster potential. We launch coverage of Insmed with a Buy recommendation and a $263 price target.
0 · Reply
Quantumup
Quantumup Dec. 4 at 1:05 PM
Rothschild & Co Redburn🏁 $INSM Buy/$263 $LQDA $UTHR Rothschild & Co Redburn said—Insmed is well positioned in large therapy areas with limited competition. With the recent approvals of Brinsupri, a first-in-class therapy for bronchiectasis, we anticipate strong uptake given the lack of competitors. Along with potential indication expansion opportunities, we believe Brinsupri has peak sales of c$12BN, above the consensus median of c$10BN. TPIP is the next important growth driver with multi-billion-dollar blockbuster potential. We launch coverage of Insmed with a Buy recommendation and a $263 price target.
0 · Reply
Outcomes
Outcomes Dec. 4 at 12:09 PM
$MNKD $UTHR https://finance.yahoo.com/news/flurry-bullish-inflows-sends-united-121929536.html
0 · Reply
HedgeAlerts
HedgeAlerts Dec. 4 at 7:05 AM
Hedge Alert Live - Protect Your Portfolio Contract: $UTHR $480.00 Put · DEC 19, 2025 Exp Entry Price: $12.30 - $15.20 Exit Price Target: $17.59 Profit Margin: +43% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 3 at 3:13 AM
$UTHR Current Stock Price: $474.14 Contracts to trade: $470 UTHR Dec 19 2025 Call Entry: $12.60 Exit: $20.75 ROI: 65% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Latest News on UTHR
Flurry of Bullish Inflows Sends United Therapeutics Higher

Dec 3, 2025, 7:19 AM EST - 3 days ago

Flurry of Bullish Inflows Sends United Therapeutics Higher


United Therapeutics Corporation - Special Call

Sep 28, 2025, 5:27 PM EDT - 2 months ago

United Therapeutics Corporation - Special Call


United Therapeutics: Is UTHR Stock Still A Buy At $400?

Sep 3, 2025, 10:10 AM EDT - 3 months ago

United Therapeutics: Is UTHR Stock Still A Buy At $400?


Why Is United Therapeutics Stock Rallying On Tuesday?

Sep 2, 2025, 10:59 AM EDT - 3 months ago

Why Is United Therapeutics Stock Rallying On Tuesday?


Earnings Summary on United Therapeutics

Jul 31, 2025, 1:23 AM EDT - 4 months ago

Earnings Summary on United Therapeutics


United Therapeutics: Don't Fear The Patent Expiration Too Much

Mar 29, 2025, 8:17 AM EDT - 9 months ago

United Therapeutics: Don't Fear The Patent Expiration Too Much


The Zen Ten - My Top Picks For 2025

Dec 29, 2024, 4:25 PM EST - 1 year ago

The Zen Ten - My Top Picks For 2025

AAPL BBW IBKR INTU META NVDA TSM


PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:04 AM
Actionable Trade Alert for $UTHR: Market Context: $UTHR closed at $484.1, showing bullish momentum but is currently overbought with an RSI of 70.14. The stock is above both the 30-day MA (459.88) and the 50-day MA (450.52), indicating a strong upward trend. However, caution is warranted due to the high RSI. Directional Bias: The bullish trend is supported by the proximity to the 60-day high of $492.62. The stock has room to move higher, but the overbought condition suggests a potential pullback. Trade Plan: - Suggested Entry: $484.1 - Stop Loss: $470.0 (3% below entry) - Take Profit Targets: 1. $490.0 (1.24% gain) 2. $495.0 (2.26% gain) 3. $510.0 (5.36% gain) Target 3 offers a potential ROI of 17% from the entry price. Monitor RSI for signs of reversal and adjust accordingly. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
VJLer
VJLer Dec. 5 at 1:55 PM
$DDD some of the narratives are incredibly exciting. I could imagine this being acqired or doing licensing deals with companies. But lately nothing is happening. Couls imagine deals with $HPQ or $UTHR or an entity that is in dental supply or a medical device company. And at current market cap the purchase price would probably be arelative pittance.
0 · Reply
clan
clan Dec. 5 at 10:13 AM
$MNKD Ya never know. $CIPLA.NSE and their $1.2TRILLION market cap could snatch up $UTHR AND Mannkind for a cool measly $50 Billion [split: Unither $40B + MannKind $10B ]. 🇮🇳🇺🇸
0 · Reply
clan
clan Dec. 5 at 9:28 AM
$MNKD is up 29% over the recent 6 months for a multitude and combination of reasons. To certainly go higher as time moves forward. Onward and upward. ↗️ In part due to $UTHR $SCPH and $BX #afrezza #inhalemyinsulin
0 · Reply
Affizle
Affizle Dec. 4 at 7:48 PM
$MNKD Food for thought $LQDA +185% YTD $UTHR +37% YTD $SPY + 16% YTD $NDAQ +16% YTD $MNKD a BIG NEGATIVE 13% YTD! oopsies for Mannkindsies! LOLZ!
0 · Reply
bemore
bemore Dec. 4 at 4:19 PM
$INSM from IV, Rothschild & Co Redburn🏁 $INSM Buy/$263 $LQDA $UTHR Rothschild & Co Redburn said—Insmed is well positioned in large therapy areas with limited competition. With the recent approvals of Brinsupri, a first-in-class therapy for bronchiectasis, we anticipate strong uptake given the lack of competitors. Along with potential indication expansion opportunities, we believe Brinsupri has peak sales of c$12BN, above the consensus median of c$10BN. TPIP is the next important growth driver with multi-billion-dollar blockbuster potential. We launch coverage of Insmed with a Buy recommendation and a $263 price target.
0 · Reply
Quantumup
Quantumup Dec. 4 at 1:05 PM
Rothschild & Co Redburn🏁 $INSM Buy/$263 $LQDA $UTHR Rothschild & Co Redburn said—Insmed is well positioned in large therapy areas with limited competition. With the recent approvals of Brinsupri, a first-in-class therapy for bronchiectasis, we anticipate strong uptake given the lack of competitors. Along with potential indication expansion opportunities, we believe Brinsupri has peak sales of c$12BN, above the consensus median of c$10BN. TPIP is the next important growth driver with multi-billion-dollar blockbuster potential. We launch coverage of Insmed with a Buy recommendation and a $263 price target.
0 · Reply
Outcomes
Outcomes Dec. 4 at 12:09 PM
$MNKD $UTHR https://finance.yahoo.com/news/flurry-bullish-inflows-sends-united-121929536.html
0 · Reply
HedgeAlerts
HedgeAlerts Dec. 4 at 7:05 AM
Hedge Alert Live - Protect Your Portfolio Contract: $UTHR $480.00 Put · DEC 19, 2025 Exp Entry Price: $12.30 - $15.20 Exit Price Target: $17.59 Profit Margin: +43% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 3 at 3:13 AM
$UTHR Current Stock Price: $474.14 Contracts to trade: $470 UTHR Dec 19 2025 Call Entry: $12.60 Exit: $20.75 ROI: 65% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Dec. 2 at 2:56 AM
0 · Reply
HedgeAlerts
HedgeAlerts Dec. 1 at 9:57 PM
Hedge Alert Live - Protect Your Portfolio Contract: $UTHR $480.00 Put · DEC 19, 2025 Exp Entry Price: $10.30 - $13.30 Exit Price Target: $21.84 Profit Margin: +112% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Estimize
Estimize Nov. 27 at 12:15 PM
Wall St is expecting 7.10 EPS for $UTHR Q4 [Reporting 02/25 BMO] http://www.estimize.com/intro/uthr?chart=historical&metric_name=eps&utm_co
0 · Reply
Outcomes
Outcomes Nov. 27 at 12:04 PM
$UTHR ....juggernaut!
0 · Reply
clan
clan Nov. 27 at 10:43 AM
$MNKD $UTHR Gobble 'til you wobble.
0 · Reply
clan
clan Nov. 27 at 7:25 AM
$MNKD $UTHR $BX 🦃🍗🌽🥧
0 · Reply
txbondman
txbondman Nov. 26 at 8:37 PM
sld some winners (partial) to take profits. sld $UTHR for a 480% gain;
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 26 at 2:12 AM
Hedge Alert Live - Protect Your Portfolio Contract: $UTHR $480.00 Put · DEC 19, 2025 Exp Entry Price: $12.60 - $16.10 Exit Price Target: $18.02 Profit Margin: +43% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Nov. 25 at 12:47 PM
$UTHR RSI: 87.06, MACD: 12.4642 Vol: 16.13, MA20: 457.56, MA50: 441.26 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 25 at 2:14 AM
Hedge Alert Live - Protect Your Portfolio Contract: $UTHR $470.00 Put · DEC 19, 2025 Exp Entry Price: $12.90 - $14.60 Exit Price Target: $23.61 Profit Margin: +83% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
NolAsrtormZ
NolAsrtormZ Nov. 24 at 3:19 PM
$GRI most recent pay out for iPf data was 4.5 B I L L I O N in market cap... ask $UTHR
0 · Reply
clan
clan Nov. 24 at 2:04 PM
$MNKD Hmmm?🤔 @DRFSR , maybe. Is $UTHR asleep at the wheel? #MoneyToBeMade #PatientsToHelp
2 · Reply